Overall, we demonstrated the cancer target-specific in vitro functions of CSPG4 IgE, and Fc-mediated effector activity restricted to target-expressing tumor cells, but not to low- or non-expressing normal cells. This evidence concerns the gene CSPG4 and neoplasm.